Collective activation of MRI agents via encapsulation and disease-triggered release.

An activation mechanism based on encapsulated ultrasmall gadolinium oxide nanoparticles (Gd oxide NPs) in bioresponsive polymer capsules capable of triggered release in response to chemical markers of disease (i.e., acidic pH, H2O2) is presented. Inside the hydrophobic polymeric matrices, the Gd oxide NPs are shielded from the aqueous environment, silencing their ability to enhance water proton relaxation. Upon disassembly of the polymeric particles, activation of multiple contrast agents generates a strong positive contrast enhancement of >1 order of magnitude.

[1]  Marc-André Fortin,et al.  Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI. , 2012, ACS applied materials & interfaces.

[2]  R. Beyers,et al.  A magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide. , 2012, Inorganic chemistry.

[3]  A. Lippert,et al.  Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems. , 2011, Accounts of chemical research.

[4]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .

[5]  Angelique Y. Louie,et al.  Activatable T1 and T2 Magnetic Resonance Imaging Contrast Agents , 2011, Annals of Biomedical Engineering.

[6]  Hisataka Kobayashi,et al.  Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. , 2011, Accounts of chemical research.

[7]  E. Gianolio,et al.  Dual MRI-SPECT agent for pH-mapping. , 2011, Chemical communications.

[8]  Marc-André Fortin,et al.  Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. , 2010, Contrast media & molecular imaging.

[9]  T. Meade,et al.  High-performance nanostructured MR contrast probes. , 2010, Nanoscale.

[10]  José M. Morachis,et al.  Multiresponse Strategies To Modulate Burst Degradation and Release from Nanoparticles , 2010, ACS nano.

[11]  M. C. Stuart,et al.  Emerging applications of stimuli-responsive polymer materials. , 2010, Nature materials.

[12]  Jean-Luc Coll,et al.  Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. , 2009, Small.

[13]  Yongmin Chang,et al.  Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. , 2009, ACS nano.

[14]  K. Leong,et al.  Electrohydrodynamics: A facile technique to fabricate drug delivery systems. , 2009, Advanced drug delivery reviews.

[15]  A. Louie,et al.  Multimodal magnetic-resonance/optical-imaging contrast agent sensitive to NADH. , 2009, Angewandte Chemie.

[16]  Thomas J Meade,et al.  Bioresponsive, cell-penetrating, and multimeric MR contrast agents. , 2009, Accounts of chemical research.

[17]  S. Cerdán,et al.  Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents. , 2008, European journal of radiology.

[18]  James B. Mitchell,et al.  Assessment of tissue redox status using metabolic responsive contrast agents and magnetic resonance imaging , 2008, The Journal of pharmacy and pharmacology.

[19]  P. Perriat,et al.  Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. , 2007, Journal of the American Chemical Society.

[20]  Peter Caravan,et al.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.

[21]  R.J. Gillies,et al.  pH imaging , 2004, IEEE Engineering in Medicine and Biology Magazine.

[22]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[23]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[24]  S. Fraser,et al.  A Calcium-Sensitive Magnetic Resonance Imaging Contrast Agent , 1999 .

[25]  I. Tannock,et al.  Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.